James A. Geraghty, Director at PIERIS PHARMACEUTICALS, INC. (PIRS), bought 10,000 shares at $5.75 ($58K) on 2018-05-15, disclosed to the SEC on 2018-05-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| VYGR | BUY | 2018-08-21 | $110K | — | Filing → |
| IDRA | BUY | 2018-08-08 | $56K | — | Filing → |
| PIRS | BUY | 2017-08-17 | $48K | — | Filing → |